换一批
换一批Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial.
第一作者：
Allan,Iversen
第一单位：
Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark. allive01@geh.regionh.dk
作者：
主题词
血管成形术, 气囊, 冠状动脉(Angioplasty, Balloon, Coronary);抗体, 单克隆(Antibodies, Monoclonal);冠状血管(Coronary Vessels);投药途径(Drug Administration Routes);女(雌)性(Female);人类(Humans);免疫球蛋白Fab片段(Immunoglobulin Fab Fragments);注射, 动脉内(Injections, Intra-Arterial);注射, 静脉内(Injections, Intravenous);男(雄)性(Male);心肌梗死(Myocardial Infarction);心肌血管重建术(Myocardial Revascularization);治疗结果(Treatment Outcome)
DOI
10.1111/j.1540-8183.2010.00616.x
PMID
21175845
发布时间
2022-03-16
- 浏览20
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
